Global Lung Cancer Screening Software Supply, Demand and Key Producers, 2026-2032
The global Lung Cancer Screening Software market size is expected to reach $ 5472 million by 2032, rising at a market growth of 17.6% CAGR during the forecast period (2026-2032).
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an 'auxiliary tool' to a 'key node in the screening process.'
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report studies the global Lung Cancer Screening Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lung Cancer Screening Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Cancer Screening Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lung Cancer Screening Software total market, 2021-2032, (USD Million)
Global Lung Cancer Screening Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lung Cancer Screening Software total market, key domestic companies, and share, (USD Million)
Global Lung Cancer Screening Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lung Cancer Screening Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Lung Cancer Screening Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lung Cancer Screening Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, InferVision, Airdoc, VUNO, Lunit, Qure.ai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lung Cancer Screening Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lung Cancer Screening Software Market, By Region:
1. How big is the global Lung Cancer Screening Software market?
2. What is the demand of the global Lung Cancer Screening Software market?
3. What is the year over year growth of the global Lung Cancer Screening Software market?
4. What is the total value of the global Lung Cancer Screening Software market?
5. Who are the Major Players in the global Lung Cancer Screening Software market?
6. What are the growth factors driving the market demand?
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an 'auxiliary tool' to a 'key node in the screening process.'
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report studies the global Lung Cancer Screening Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lung Cancer Screening Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Cancer Screening Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lung Cancer Screening Software total market, 2021-2032, (USD Million)
Global Lung Cancer Screening Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lung Cancer Screening Software total market, key domestic companies, and share, (USD Million)
Global Lung Cancer Screening Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lung Cancer Screening Software total market by Type, CAGR, 2021-2032, (USD Million)
Global Lung Cancer Screening Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lung Cancer Screening Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, InferVision, Airdoc, VUNO, Lunit, Qure.ai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lung Cancer Screening Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lung Cancer Screening Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cloud-Based
- Web-Based
- Nodule Detection
- Nodule Analysis
- Full-Process Screening
- Predictive Assessment
- Standalone AI Software
- PACS/RIS Integrated Plugin
- Built-in Solution for Imaging Equipment
- Regional Screening Platform System
- Hospitals
- Medical Examination Institutions
- Public Health Screening
- Others
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- InferVision
- Airdoc
- VUNO
- Lunit
- Qure.ai
- Riverain Technologies
- Zebra Medical Vision
- Arterys
- Deepwise
- EverFortune AI
1. How big is the global Lung Cancer Screening Software market?
2. What is the demand of the global Lung Cancer Screening Software market?
3. What is the year over year growth of the global Lung Cancer Screening Software market?
4. What is the total value of the global Lung Cancer Screening Software market?
5. Who are the Major Players in the global Lung Cancer Screening Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Lung Cancer Screening Software Introduction
1.2 World Lung Cancer Screening Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lung Cancer Screening Software Total Market by Region (by Headquarter Location)
1.3.1 World Lung Cancer Screening Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.3 China Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.4 Europe Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.5 Japan Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.6 South Korea Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.8 India Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lung Cancer Screening Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lung Cancer Screening Software Consumption Value (2021-2032)
2.2 World Lung Cancer Screening Software Consumption Value by Region
2.2.1 World Lung Cancer Screening Software Consumption Value by Region (2021-2026)
2.2.2 World Lung Cancer Screening Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Lung Cancer Screening Software Consumption Value (2021-2032)
2.4 China Lung Cancer Screening Software Consumption Value (2021-2032)
2.5 Europe Lung Cancer Screening Software Consumption Value (2021-2032)
2.6 Japan Lung Cancer Screening Software Consumption Value (2021-2032)
2.7 South Korea Lung Cancer Screening Software Consumption Value (2021-2032)
2.8 ASEAN Lung Cancer Screening Software Consumption Value (2021-2032)
2.9 India Lung Cancer Screening Software Consumption Value (2021-2032)
3 WORLD LUNG CANCER SCREENING SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lung Cancer Screening Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lung Cancer Screening Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lung Cancer Screening Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Lung Cancer Screening Software in 2025
3.3 Lung Cancer Screening Software Company Evaluation Quadrant
3.4 Lung Cancer Screening Software Market: Overall Company Footprint Analysis
3.4.1 Lung Cancer Screening Software Market: Region Footprint
3.4.2 Lung Cancer Screening Software Market: Company Product Type Footprint
3.4.3 Lung Cancer Screening Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lung Cancer Screening Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lung Cancer Screening Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lung Cancer Screening Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lung Cancer Screening Software Consumption Value Comparison
4.2.1 United States VS China: Lung Cancer Screening Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lung Cancer Screening Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lung Cancer Screening Software Companies and Market Share, 2021-2026
4.3.1 United States Based Lung Cancer Screening Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lung Cancer Screening Software Revenue, (2021-2026)
4.4 China Based Companies Lung Cancer Screening Software Revenue and Market Share, 2021-2026
4.4.1 China Based Lung Cancer Screening Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lung Cancer Screening Software Revenue, (2021-2026)
4.5 Rest of World Based Lung Cancer Screening Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lung Cancer Screening Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lung Cancer Screening Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud-Based
5.2.2 Web-Based
5.3 Market Segment by Type
5.3.1 World Lung Cancer Screening Software Market Size by Type (2021-2026)
5.3.2 World Lung Cancer Screening Software Market Size by Type (2027-2032)
5.3.3 World Lung Cancer Screening Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TECHNOLOGIES
6.1 World Lung Cancer Screening Software Market Size Overview by Screening Technologies: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Technologies
6.2.1 Nodule Detection
6.2.2 Nodule Analysis
6.2.3 Full-Process Screening
6.2.4 Predictive Assessment
6.3 Market Segment by Screening Technologies
6.3.1 World Lung Cancer Screening Software Market Size by Screening Technologies (2021-2026)
6.3.2 World Lung Cancer Screening Software Market Size by Screening Technologies (2027-2032)
6.3.3 World Lung Cancer Screening Software Market Size Market Share by Screening Technologies (2027-2032)
7 MARKET ANALYSIS BY SYSTEM INTEGRATION LEVEL
7.1 World Lung Cancer Screening Software Market Size Overview by System Integration Level: 2021 VS 2025 VS 2032
7.2 Segment Introduction by System Integration Level
7.2.1 Standalone AI Software
7.2.2 PACS/RIS Integrated Plugin
7.2.3 Built-in Solution for Imaging Equipment
7.2.4 Regional Screening Platform System
7.3 Market Segment by System Integration Level
7.3.1 World Lung Cancer Screening Software Market Size by System Integration Level (2021-2026)
7.3.2 World Lung Cancer Screening Software Market Size by System Integration Level (2027-2032)
7.3.3 World Lung Cancer Screening Software Market Size Market Share by System Integration Level (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lung Cancer Screening Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Medical Examination Institutions
8.2.3 Public Health Screening
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lung Cancer Screening Software Market Size by Application (2021-2026)
8.3.2 World Lung Cancer Screening Software Market Size by Application (2027-2032)
8.3.3 World Lung Cancer Screening Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Siemens Healthineers
9.1.1 Siemens Healthineers Details
9.1.2 Siemens Healthineers Major Business
9.1.3 Siemens Healthineers Lung Cancer Screening Software Product and Services
9.1.4 Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Siemens Healthineers Recent Developments/Updates
9.1.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.2 GE HealthCare
9.2.1 GE HealthCare Details
9.2.2 GE HealthCare Major Business
9.2.3 GE HealthCare Lung Cancer Screening Software Product and Services
9.2.4 GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 GE HealthCare Recent Developments/Updates
9.2.6 GE HealthCare Competitive Strengths & Weaknesses
9.3 Philips Healthcare
9.3.1 Philips Healthcare Details
9.3.2 Philips Healthcare Major Business
9.3.3 Philips Healthcare Lung Cancer Screening Software Product and Services
9.3.4 Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Philips Healthcare Recent Developments/Updates
9.3.6 Philips Healthcare Competitive Strengths & Weaknesses
9.4 Canon Medical Systems
9.4.1 Canon Medical Systems Details
9.4.2 Canon Medical Systems Major Business
9.4.3 Canon Medical Systems Lung Cancer Screening Software Product and Services
9.4.4 Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Canon Medical Systems Recent Developments/Updates
9.4.6 Canon Medical Systems Competitive Strengths & Weaknesses
9.5 United Imaging Healthcare
9.5.1 United Imaging Healthcare Details
9.5.2 United Imaging Healthcare Major Business
9.5.3 United Imaging Healthcare Lung Cancer Screening Software Product and Services
9.5.4 United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 United Imaging Healthcare Recent Developments/Updates
9.5.6 United Imaging Healthcare Competitive Strengths & Weaknesses
9.6 InferVision
9.6.1 InferVision Details
9.6.2 InferVision Major Business
9.6.3 InferVision Lung Cancer Screening Software Product and Services
9.6.4 InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 InferVision Recent Developments/Updates
9.6.6 InferVision Competitive Strengths & Weaknesses
9.7 Airdoc
9.7.1 Airdoc Details
9.7.2 Airdoc Major Business
9.7.3 Airdoc Lung Cancer Screening Software Product and Services
9.7.4 Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Airdoc Recent Developments/Updates
9.7.6 Airdoc Competitive Strengths & Weaknesses
9.8 VUNO
9.8.1 VUNO Details
9.8.2 VUNO Major Business
9.8.3 VUNO Lung Cancer Screening Software Product and Services
9.8.4 VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 VUNO Recent Developments/Updates
9.8.6 VUNO Competitive Strengths & Weaknesses
9.9 Lunit
9.9.1 Lunit Details
9.9.2 Lunit Major Business
9.9.3 Lunit Lung Cancer Screening Software Product and Services
9.9.4 Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Lunit Recent Developments/Updates
9.9.6 Lunit Competitive Strengths & Weaknesses
9.10 Qure.ai
9.10.1 Qure.ai Details
9.10.2 Qure.ai Major Business
9.10.3 Qure.ai Lung Cancer Screening Software Product and Services
9.10.4 Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Qure.ai Recent Developments/Updates
9.10.6 Qure.ai Competitive Strengths & Weaknesses
9.11 Riverain Technologies
9.11.1 Riverain Technologies Details
9.11.2 Riverain Technologies Major Business
9.11.3 Riverain Technologies Lung Cancer Screening Software Product and Services
9.11.4 Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Riverain Technologies Recent Developments/Updates
9.11.6 Riverain Technologies Competitive Strengths & Weaknesses
9.12 Zebra Medical Vision
9.12.1 Zebra Medical Vision Details
9.12.2 Zebra Medical Vision Major Business
9.12.3 Zebra Medical Vision Lung Cancer Screening Software Product and Services
9.12.4 Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Zebra Medical Vision Recent Developments/Updates
9.12.6 Zebra Medical Vision Competitive Strengths & Weaknesses
9.13 Arterys
9.13.1 Arterys Details
9.13.2 Arterys Major Business
9.13.3 Arterys Lung Cancer Screening Software Product and Services
9.13.4 Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Arterys Recent Developments/Updates
9.13.6 Arterys Competitive Strengths & Weaknesses
9.14 Deepwise
9.14.1 Deepwise Details
9.14.2 Deepwise Major Business
9.14.3 Deepwise Lung Cancer Screening Software Product and Services
9.14.4 Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Deepwise Recent Developments/Updates
9.14.6 Deepwise Competitive Strengths & Weaknesses
9.15 EverFortune AI
9.15.1 EverFortune AI Details
9.15.2 EverFortune AI Major Business
9.15.3 EverFortune AI Lung Cancer Screening Software Product and Services
9.15.4 EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 EverFortune AI Recent Developments/Updates
9.15.6 EverFortune AI Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lung Cancer Screening Software Industry Chain
10.2 Lung Cancer Screening Software Upstream Analysis
10.3 Lung Cancer Screening Software Midstream Analysis
10.4 Lung Cancer Screening Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Lung Cancer Screening Software Introduction
1.2 World Lung Cancer Screening Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lung Cancer Screening Software Total Market by Region (by Headquarter Location)
1.3.1 World Lung Cancer Screening Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.3 China Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.4 Europe Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.5 Japan Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.6 South Korea Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.3.8 India Based Company Lung Cancer Screening Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lung Cancer Screening Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lung Cancer Screening Software Consumption Value (2021-2032)
2.2 World Lung Cancer Screening Software Consumption Value by Region
2.2.1 World Lung Cancer Screening Software Consumption Value by Region (2021-2026)
2.2.2 World Lung Cancer Screening Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Lung Cancer Screening Software Consumption Value (2021-2032)
2.4 China Lung Cancer Screening Software Consumption Value (2021-2032)
2.5 Europe Lung Cancer Screening Software Consumption Value (2021-2032)
2.6 Japan Lung Cancer Screening Software Consumption Value (2021-2032)
2.7 South Korea Lung Cancer Screening Software Consumption Value (2021-2032)
2.8 ASEAN Lung Cancer Screening Software Consumption Value (2021-2032)
2.9 India Lung Cancer Screening Software Consumption Value (2021-2032)
3 WORLD LUNG CANCER SCREENING SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lung Cancer Screening Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lung Cancer Screening Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lung Cancer Screening Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Lung Cancer Screening Software in 2025
3.3 Lung Cancer Screening Software Company Evaluation Quadrant
3.4 Lung Cancer Screening Software Market: Overall Company Footprint Analysis
3.4.1 Lung Cancer Screening Software Market: Region Footprint
3.4.2 Lung Cancer Screening Software Market: Company Product Type Footprint
3.4.3 Lung Cancer Screening Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lung Cancer Screening Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lung Cancer Screening Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lung Cancer Screening Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lung Cancer Screening Software Consumption Value Comparison
4.2.1 United States VS China: Lung Cancer Screening Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lung Cancer Screening Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lung Cancer Screening Software Companies and Market Share, 2021-2026
4.3.1 United States Based Lung Cancer Screening Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lung Cancer Screening Software Revenue, (2021-2026)
4.4 China Based Companies Lung Cancer Screening Software Revenue and Market Share, 2021-2026
4.4.1 China Based Lung Cancer Screening Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lung Cancer Screening Software Revenue, (2021-2026)
4.5 Rest of World Based Lung Cancer Screening Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lung Cancer Screening Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lung Cancer Screening Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud-Based
5.2.2 Web-Based
5.3 Market Segment by Type
5.3.1 World Lung Cancer Screening Software Market Size by Type (2021-2026)
5.3.2 World Lung Cancer Screening Software Market Size by Type (2027-2032)
5.3.3 World Lung Cancer Screening Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TECHNOLOGIES
6.1 World Lung Cancer Screening Software Market Size Overview by Screening Technologies: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Technologies
6.2.1 Nodule Detection
6.2.2 Nodule Analysis
6.2.3 Full-Process Screening
6.2.4 Predictive Assessment
6.3 Market Segment by Screening Technologies
6.3.1 World Lung Cancer Screening Software Market Size by Screening Technologies (2021-2026)
6.3.2 World Lung Cancer Screening Software Market Size by Screening Technologies (2027-2032)
6.3.3 World Lung Cancer Screening Software Market Size Market Share by Screening Technologies (2027-2032)
7 MARKET ANALYSIS BY SYSTEM INTEGRATION LEVEL
7.1 World Lung Cancer Screening Software Market Size Overview by System Integration Level: 2021 VS 2025 VS 2032
7.2 Segment Introduction by System Integration Level
7.2.1 Standalone AI Software
7.2.2 PACS/RIS Integrated Plugin
7.2.3 Built-in Solution for Imaging Equipment
7.2.4 Regional Screening Platform System
7.3 Market Segment by System Integration Level
7.3.1 World Lung Cancer Screening Software Market Size by System Integration Level (2021-2026)
7.3.2 World Lung Cancer Screening Software Market Size by System Integration Level (2027-2032)
7.3.3 World Lung Cancer Screening Software Market Size Market Share by System Integration Level (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lung Cancer Screening Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Medical Examination Institutions
8.2.3 Public Health Screening
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lung Cancer Screening Software Market Size by Application (2021-2026)
8.3.2 World Lung Cancer Screening Software Market Size by Application (2027-2032)
8.3.3 World Lung Cancer Screening Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Siemens Healthineers
9.1.1 Siemens Healthineers Details
9.1.2 Siemens Healthineers Major Business
9.1.3 Siemens Healthineers Lung Cancer Screening Software Product and Services
9.1.4 Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Siemens Healthineers Recent Developments/Updates
9.1.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.2 GE HealthCare
9.2.1 GE HealthCare Details
9.2.2 GE HealthCare Major Business
9.2.3 GE HealthCare Lung Cancer Screening Software Product and Services
9.2.4 GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 GE HealthCare Recent Developments/Updates
9.2.6 GE HealthCare Competitive Strengths & Weaknesses
9.3 Philips Healthcare
9.3.1 Philips Healthcare Details
9.3.2 Philips Healthcare Major Business
9.3.3 Philips Healthcare Lung Cancer Screening Software Product and Services
9.3.4 Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Philips Healthcare Recent Developments/Updates
9.3.6 Philips Healthcare Competitive Strengths & Weaknesses
9.4 Canon Medical Systems
9.4.1 Canon Medical Systems Details
9.4.2 Canon Medical Systems Major Business
9.4.3 Canon Medical Systems Lung Cancer Screening Software Product and Services
9.4.4 Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Canon Medical Systems Recent Developments/Updates
9.4.6 Canon Medical Systems Competitive Strengths & Weaknesses
9.5 United Imaging Healthcare
9.5.1 United Imaging Healthcare Details
9.5.2 United Imaging Healthcare Major Business
9.5.3 United Imaging Healthcare Lung Cancer Screening Software Product and Services
9.5.4 United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 United Imaging Healthcare Recent Developments/Updates
9.5.6 United Imaging Healthcare Competitive Strengths & Weaknesses
9.6 InferVision
9.6.1 InferVision Details
9.6.2 InferVision Major Business
9.6.3 InferVision Lung Cancer Screening Software Product and Services
9.6.4 InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 InferVision Recent Developments/Updates
9.6.6 InferVision Competitive Strengths & Weaknesses
9.7 Airdoc
9.7.1 Airdoc Details
9.7.2 Airdoc Major Business
9.7.3 Airdoc Lung Cancer Screening Software Product and Services
9.7.4 Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Airdoc Recent Developments/Updates
9.7.6 Airdoc Competitive Strengths & Weaknesses
9.8 VUNO
9.8.1 VUNO Details
9.8.2 VUNO Major Business
9.8.3 VUNO Lung Cancer Screening Software Product and Services
9.8.4 VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 VUNO Recent Developments/Updates
9.8.6 VUNO Competitive Strengths & Weaknesses
9.9 Lunit
9.9.1 Lunit Details
9.9.2 Lunit Major Business
9.9.3 Lunit Lung Cancer Screening Software Product and Services
9.9.4 Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Lunit Recent Developments/Updates
9.9.6 Lunit Competitive Strengths & Weaknesses
9.10 Qure.ai
9.10.1 Qure.ai Details
9.10.2 Qure.ai Major Business
9.10.3 Qure.ai Lung Cancer Screening Software Product and Services
9.10.4 Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Qure.ai Recent Developments/Updates
9.10.6 Qure.ai Competitive Strengths & Weaknesses
9.11 Riverain Technologies
9.11.1 Riverain Technologies Details
9.11.2 Riverain Technologies Major Business
9.11.3 Riverain Technologies Lung Cancer Screening Software Product and Services
9.11.4 Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Riverain Technologies Recent Developments/Updates
9.11.6 Riverain Technologies Competitive Strengths & Weaknesses
9.12 Zebra Medical Vision
9.12.1 Zebra Medical Vision Details
9.12.2 Zebra Medical Vision Major Business
9.12.3 Zebra Medical Vision Lung Cancer Screening Software Product and Services
9.12.4 Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Zebra Medical Vision Recent Developments/Updates
9.12.6 Zebra Medical Vision Competitive Strengths & Weaknesses
9.13 Arterys
9.13.1 Arterys Details
9.13.2 Arterys Major Business
9.13.3 Arterys Lung Cancer Screening Software Product and Services
9.13.4 Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Arterys Recent Developments/Updates
9.13.6 Arterys Competitive Strengths & Weaknesses
9.14 Deepwise
9.14.1 Deepwise Details
9.14.2 Deepwise Major Business
9.14.3 Deepwise Lung Cancer Screening Software Product and Services
9.14.4 Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Deepwise Recent Developments/Updates
9.14.6 Deepwise Competitive Strengths & Weaknesses
9.15 EverFortune AI
9.15.1 EverFortune AI Details
9.15.2 EverFortune AI Major Business
9.15.3 EverFortune AI Lung Cancer Screening Software Product and Services
9.15.4 EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 EverFortune AI Recent Developments/Updates
9.15.6 EverFortune AI Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lung Cancer Screening Software Industry Chain
10.2 Lung Cancer Screening Software Upstream Analysis
10.3 Lung Cancer Screening Software Midstream Analysis
10.4 Lung Cancer Screening Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Lung Cancer Screening Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lung Cancer Screening Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lung Cancer Screening Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lung Cancer Screening Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lung Cancer Screening Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lung Cancer Screening Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lung Cancer Screening Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lung Cancer Screening Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lung Cancer Screening Software Players in 2025
Table 12. World Lung Cancer Screening Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lung Cancer Screening Software Company Evaluation Quadrant
Table 14. Head Office of Key Lung Cancer Screening Software Players
Table 15. Lung Cancer Screening Software Market: Company Product Type Footprint
Table 16. Lung Cancer Screening Software Market: Company Product Application Footprint
Table 17. Lung Cancer Screening Software Mergers & Acquisitions Activity
Table 18. United States VS China Lung Cancer Screening Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lung Cancer Screening Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lung Cancer Screening Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lung Cancer Screening Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 23. China Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lung Cancer Screening Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lung Cancer Screening Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 29. World Lung Cancer Screening Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lung Cancer Screening Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lung Cancer Screening Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lung Cancer Screening Software Market Size by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Table 33. World Lung Cancer Screening Software Market Size Value by Screening Technologies (2021-2026) & (USD Million)
Table 34. World Lung Cancer Screening Software Market Size by Screening Technologies (2027-2032) & (USD Million)
Table 35. World Lung Cancer Screening Software Market Size by System Integration Level, (USD Million), 2021 & 2025 & 2032
Table 36. World Lung Cancer Screening Software Market Size Value by System Integration Level (2021-2026) & (USD Million)
Table 37. World Lung Cancer Screening Software Market Size by System Integration Level (2027-2032) & (USD Million)
Table 38. World Lung Cancer Screening Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lung Cancer Screening Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lung Cancer Screening Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 42. Siemens Healthineers Major Business
Table 43. Siemens Healthineers Lung Cancer Screening Software Product and Services
Table 44. Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Siemens Healthineers Recent Developments/Updates
Table 46. Siemens Healthineers Competitive Strengths & Weaknesses
Table 47. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 48. GE HealthCare Major Business
Table 49. GE HealthCare Lung Cancer Screening Software Product and Services
Table 50. GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. GE HealthCare Recent Developments/Updates
Table 52. GE HealthCare Competitive Strengths & Weaknesses
Table 53. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 54. Philips Healthcare Major Business
Table 55. Philips Healthcare Lung Cancer Screening Software Product and Services
Table 56. Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Philips Healthcare Recent Developments/Updates
Table 58. Philips Healthcare Competitive Strengths & Weaknesses
Table 59. Canon Medical Systems Basic Information, Manufacturing Base and Competitors
Table 60. Canon Medical Systems Major Business
Table 61. Canon Medical Systems Lung Cancer Screening Software Product and Services
Table 62. Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Canon Medical Systems Recent Developments/Updates
Table 64. Canon Medical Systems Competitive Strengths & Weaknesses
Table 65. United Imaging Healthcare Basic Information, Manufacturing Base and Competitors
Table 66. United Imaging Healthcare Major Business
Table 67. United Imaging Healthcare Lung Cancer Screening Software Product and Services
Table 68. United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. United Imaging Healthcare Recent Developments/Updates
Table 70. United Imaging Healthcare Competitive Strengths & Weaknesses
Table 71. InferVision Basic Information, Manufacturing Base and Competitors
Table 72. InferVision Major Business
Table 73. InferVision Lung Cancer Screening Software Product and Services
Table 74. InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. InferVision Recent Developments/Updates
Table 76. InferVision Competitive Strengths & Weaknesses
Table 77. Airdoc Basic Information, Manufacturing Base and Competitors
Table 78. Airdoc Major Business
Table 79. Airdoc Lung Cancer Screening Software Product and Services
Table 80. Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Airdoc Recent Developments/Updates
Table 82. Airdoc Competitive Strengths & Weaknesses
Table 83. VUNO Basic Information, Manufacturing Base and Competitors
Table 84. VUNO Major Business
Table 85. VUNO Lung Cancer Screening Software Product and Services
Table 86. VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. VUNO Recent Developments/Updates
Table 88. VUNO Competitive Strengths & Weaknesses
Table 89. Lunit Basic Information, Manufacturing Base and Competitors
Table 90. Lunit Major Business
Table 91. Lunit Lung Cancer Screening Software Product and Services
Table 92. Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lunit Recent Developments/Updates
Table 94. Lunit Competitive Strengths & Weaknesses
Table 95. Qure.ai Basic Information, Manufacturing Base and Competitors
Table 96. Qure.ai Major Business
Table 97. Qure.ai Lung Cancer Screening Software Product and Services
Table 98. Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Qure.ai Recent Developments/Updates
Table 100. Qure.ai Competitive Strengths & Weaknesses
Table 101. Riverain Technologies Basic Information, Manufacturing Base and Competitors
Table 102. Riverain Technologies Major Business
Table 103. Riverain Technologies Lung Cancer Screening Software Product and Services
Table 104. Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Riverain Technologies Recent Developments/Updates
Table 106. Riverain Technologies Competitive Strengths & Weaknesses
Table 107. Zebra Medical Vision Basic Information, Manufacturing Base and Competitors
Table 108. Zebra Medical Vision Major Business
Table 109. Zebra Medical Vision Lung Cancer Screening Software Product and Services
Table 110. Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Zebra Medical Vision Recent Developments/Updates
Table 112. Zebra Medical Vision Competitive Strengths & Weaknesses
Table 113. Arterys Basic Information, Manufacturing Base and Competitors
Table 114. Arterys Major Business
Table 115. Arterys Lung Cancer Screening Software Product and Services
Table 116. Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Arterys Recent Developments/Updates
Table 118. Arterys Competitive Strengths & Weaknesses
Table 119. Deepwise Basic Information, Manufacturing Base and Competitors
Table 120. Deepwise Major Business
Table 121. Deepwise Lung Cancer Screening Software Product and Services
Table 122. Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Deepwise Recent Developments/Updates
Table 124. Deepwise Competitive Strengths & Weaknesses
Table 125. EverFortune AI Basic Information, Manufacturing Base and Competitors
Table 126. EverFortune AI Major Business
Table 127. EverFortune AI Lung Cancer Screening Software Product and Services
Table 128. EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. EverFortune AI Recent Developments/Updates
Table 130. EverFortune AI Competitive Strengths & Weaknesses
Table 131. Global Key Players of Lung Cancer Screening Software Upstream (Raw Materials)
Table 132. Global Lung Cancer Screening Software Typical Customers
Table 1. World Lung Cancer Screening Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lung Cancer Screening Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lung Cancer Screening Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lung Cancer Screening Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lung Cancer Screening Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lung Cancer Screening Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lung Cancer Screening Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lung Cancer Screening Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lung Cancer Screening Software Players in 2025
Table 12. World Lung Cancer Screening Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lung Cancer Screening Software Company Evaluation Quadrant
Table 14. Head Office of Key Lung Cancer Screening Software Players
Table 15. Lung Cancer Screening Software Market: Company Product Type Footprint
Table 16. Lung Cancer Screening Software Market: Company Product Application Footprint
Table 17. Lung Cancer Screening Software Mergers & Acquisitions Activity
Table 18. United States VS China Lung Cancer Screening Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lung Cancer Screening Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lung Cancer Screening Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lung Cancer Screening Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 23. China Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lung Cancer Screening Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lung Cancer Screening Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lung Cancer Screening Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lung Cancer Screening Software Revenue Market Share (2021-2026)
Table 29. World Lung Cancer Screening Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lung Cancer Screening Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lung Cancer Screening Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lung Cancer Screening Software Market Size by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Table 33. World Lung Cancer Screening Software Market Size Value by Screening Technologies (2021-2026) & (USD Million)
Table 34. World Lung Cancer Screening Software Market Size by Screening Technologies (2027-2032) & (USD Million)
Table 35. World Lung Cancer Screening Software Market Size by System Integration Level, (USD Million), 2021 & 2025 & 2032
Table 36. World Lung Cancer Screening Software Market Size Value by System Integration Level (2021-2026) & (USD Million)
Table 37. World Lung Cancer Screening Software Market Size by System Integration Level (2027-2032) & (USD Million)
Table 38. World Lung Cancer Screening Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lung Cancer Screening Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lung Cancer Screening Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 42. Siemens Healthineers Major Business
Table 43. Siemens Healthineers Lung Cancer Screening Software Product and Services
Table 44. Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Siemens Healthineers Recent Developments/Updates
Table 46. Siemens Healthineers Competitive Strengths & Weaknesses
Table 47. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 48. GE HealthCare Major Business
Table 49. GE HealthCare Lung Cancer Screening Software Product and Services
Table 50. GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. GE HealthCare Recent Developments/Updates
Table 52. GE HealthCare Competitive Strengths & Weaknesses
Table 53. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 54. Philips Healthcare Major Business
Table 55. Philips Healthcare Lung Cancer Screening Software Product and Services
Table 56. Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Philips Healthcare Recent Developments/Updates
Table 58. Philips Healthcare Competitive Strengths & Weaknesses
Table 59. Canon Medical Systems Basic Information, Manufacturing Base and Competitors
Table 60. Canon Medical Systems Major Business
Table 61. Canon Medical Systems Lung Cancer Screening Software Product and Services
Table 62. Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Canon Medical Systems Recent Developments/Updates
Table 64. Canon Medical Systems Competitive Strengths & Weaknesses
Table 65. United Imaging Healthcare Basic Information, Manufacturing Base and Competitors
Table 66. United Imaging Healthcare Major Business
Table 67. United Imaging Healthcare Lung Cancer Screening Software Product and Services
Table 68. United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. United Imaging Healthcare Recent Developments/Updates
Table 70. United Imaging Healthcare Competitive Strengths & Weaknesses
Table 71. InferVision Basic Information, Manufacturing Base and Competitors
Table 72. InferVision Major Business
Table 73. InferVision Lung Cancer Screening Software Product and Services
Table 74. InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. InferVision Recent Developments/Updates
Table 76. InferVision Competitive Strengths & Weaknesses
Table 77. Airdoc Basic Information, Manufacturing Base and Competitors
Table 78. Airdoc Major Business
Table 79. Airdoc Lung Cancer Screening Software Product and Services
Table 80. Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Airdoc Recent Developments/Updates
Table 82. Airdoc Competitive Strengths & Weaknesses
Table 83. VUNO Basic Information, Manufacturing Base and Competitors
Table 84. VUNO Major Business
Table 85. VUNO Lung Cancer Screening Software Product and Services
Table 86. VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. VUNO Recent Developments/Updates
Table 88. VUNO Competitive Strengths & Weaknesses
Table 89. Lunit Basic Information, Manufacturing Base and Competitors
Table 90. Lunit Major Business
Table 91. Lunit Lung Cancer Screening Software Product and Services
Table 92. Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Lunit Recent Developments/Updates
Table 94. Lunit Competitive Strengths & Weaknesses
Table 95. Qure.ai Basic Information, Manufacturing Base and Competitors
Table 96. Qure.ai Major Business
Table 97. Qure.ai Lung Cancer Screening Software Product and Services
Table 98. Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Qure.ai Recent Developments/Updates
Table 100. Qure.ai Competitive Strengths & Weaknesses
Table 101. Riverain Technologies Basic Information, Manufacturing Base and Competitors
Table 102. Riverain Technologies Major Business
Table 103. Riverain Technologies Lung Cancer Screening Software Product and Services
Table 104. Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Riverain Technologies Recent Developments/Updates
Table 106. Riverain Technologies Competitive Strengths & Weaknesses
Table 107. Zebra Medical Vision Basic Information, Manufacturing Base and Competitors
Table 108. Zebra Medical Vision Major Business
Table 109. Zebra Medical Vision Lung Cancer Screening Software Product and Services
Table 110. Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Zebra Medical Vision Recent Developments/Updates
Table 112. Zebra Medical Vision Competitive Strengths & Weaknesses
Table 113. Arterys Basic Information, Manufacturing Base and Competitors
Table 114. Arterys Major Business
Table 115. Arterys Lung Cancer Screening Software Product and Services
Table 116. Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Arterys Recent Developments/Updates
Table 118. Arterys Competitive Strengths & Weaknesses
Table 119. Deepwise Basic Information, Manufacturing Base and Competitors
Table 120. Deepwise Major Business
Table 121. Deepwise Lung Cancer Screening Software Product and Services
Table 122. Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Deepwise Recent Developments/Updates
Table 124. Deepwise Competitive Strengths & Weaknesses
Table 125. EverFortune AI Basic Information, Manufacturing Base and Competitors
Table 126. EverFortune AI Major Business
Table 127. EverFortune AI Lung Cancer Screening Software Product and Services
Table 128. EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. EverFortune AI Recent Developments/Updates
Table 130. EverFortune AI Competitive Strengths & Weaknesses
Table 131. Global Key Players of Lung Cancer Screening Software Upstream (Raw Materials)
Table 132. Global Lung Cancer Screening Software Typical Customers
LIST OF FIGURES
Figure 1. Lung Cancer Screening Software Picture
Figure 2. World Lung Cancer Screening Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lung Cancer Screening Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lung Cancer Screening Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lung Cancer Screening Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 13. Lung Cancer Screening Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lung Cancer Screening Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lung Cancer Screening Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lung Cancer Screening Software Markets in 2025
Figure 27. United States VS China: Lung Cancer Screening Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lung Cancer Screening Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lung Cancer Screening Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lung Cancer Screening Software Market Size Market Share by Type in 2025
Figure 31. Cloud-Based
Figure 32. Web-Based
Figure 33. World Lung Cancer Screening Software Market Size Market Share by Type (2021-2032)
Figure 34. World Lung Cancer Screening Software Market Size by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Figure 35. World Lung Cancer Screening Software Market Size Market Share by Screening Technologies in 2025
Figure 36. Nodule Detection
Figure 37. Nodule Analysis
Figure 38. Full-Process Screening
Figure 39. Predictive Assessment
Figure 40. World Lung Cancer Screening Software Market Size Market Share by Screening Technologies (2021-2032)
Figure 41. World Lung Cancer Screening Software Market Size by System Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 42. World Lung Cancer Screening Software Market Size Market Share by System Integration Level in 2025
Figure 43. Standalone AI Software
Figure 44. PACS/RIS Integrated Plugin
Figure 45. Built-in Solution for Imaging Equipment
Figure 46. Regional Screening Platform System
Figure 47. World Lung Cancer Screening Software Market Size Market Share by System Integration Level (2021-2032)
Figure 48. World Lung Cancer Screening Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Lung Cancer Screening Software Market Size Market Share by Application in 2025
Figure 50. Hospitals
Figure 51. Medical Examination Institutions
Figure 52. Public Health Screening
Figure 53. Others
Figure 54. World Lung Cancer Screening Software Market Size Market Share by Application (2021-2032)
Figure 55. Lung Cancer Screening Software Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Lung Cancer Screening Software Picture
Figure 2. World Lung Cancer Screening Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lung Cancer Screening Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lung Cancer Screening Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lung Cancer Screening Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lung Cancer Screening Software Revenue (2021-2032) & (USD Million)
Figure 13. Lung Cancer Screening Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lung Cancer Screening Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lung Cancer Screening Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lung Cancer Screening Software Markets in 2025
Figure 27. United States VS China: Lung Cancer Screening Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lung Cancer Screening Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lung Cancer Screening Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lung Cancer Screening Software Market Size Market Share by Type in 2025
Figure 31. Cloud-Based
Figure 32. Web-Based
Figure 33. World Lung Cancer Screening Software Market Size Market Share by Type (2021-2032)
Figure 34. World Lung Cancer Screening Software Market Size by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Figure 35. World Lung Cancer Screening Software Market Size Market Share by Screening Technologies in 2025
Figure 36. Nodule Detection
Figure 37. Nodule Analysis
Figure 38. Full-Process Screening
Figure 39. Predictive Assessment
Figure 40. World Lung Cancer Screening Software Market Size Market Share by Screening Technologies (2021-2032)
Figure 41. World Lung Cancer Screening Software Market Size by System Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 42. World Lung Cancer Screening Software Market Size Market Share by System Integration Level in 2025
Figure 43. Standalone AI Software
Figure 44. PACS/RIS Integrated Plugin
Figure 45. Built-in Solution for Imaging Equipment
Figure 46. Regional Screening Platform System
Figure 47. World Lung Cancer Screening Software Market Size Market Share by System Integration Level (2021-2032)
Figure 48. World Lung Cancer Screening Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Lung Cancer Screening Software Market Size Market Share by Application in 2025
Figure 50. Hospitals
Figure 51. Medical Examination Institutions
Figure 52. Public Health Screening
Figure 53. Others
Figure 54. World Lung Cancer Screening Software Market Size Market Share by Application (2021-2032)
Figure 55. Lung Cancer Screening Software Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
